Is BPC 157 Banned? Oral vs. Injectable Forms Explained BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Wolverine Stack Peptide Therapy (BPC 157 + TB 500) $330 OFH BPC 157 Explained: Benefits, Safety & Oral vs Injectable Options There's a common misconception about peptide injections that targeting them directly at pain sites is more effective than abdominal injection. However, when you inject peptides like BPC 157